Stay updated on Durvalumab Combo in Pleural Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo in Pleural Mesothelioma Clinical Trial page.

Latest updates to the Durvalumab Combo in Pleural Mesothelioma Clinical Trial page
- ChecktodayChange DetectedThe DREAM3R trial history now lists version 74, submitted September 30, 2026, with changes to Study Status and Outcome Measures, including results.SummaryDifference0.6%

- Check7 days agoChange DetectedThe footer revision label was updated from v3.7.1 to v3.7.2.SummaryDifference0.0%

- Check14 days agoChange DetectedThe site footer revision number changed from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check21 days agoChange DetectedThe study record now indicates that results have been posted, with updates to outcome measures and adverse-event information. The history also reflects a new version and a change from “Results Submitted” to “Results Posted.”SummaryDifference0.4%

- Check35 days agoChange DetectedRecord history now shows the latest revision as v3.7.0, replacing the previous v3.6.6. This reflects a software update to the page rather than changes to study information.SummaryDifference0.0%

- Check49 days agoChange DetectedVersion 72 is now listed with a return date of 2026-08-31 and a QC status of Has Not Concluded. The update also adds new sections for Outcome Measures (Results) and Document Section to the study record history.SummaryDifference0.4%

Stay in the know with updates to Durvalumab Combo in Pleural Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Pleural Mesothelioma Clinical Trial page.